Over the counter treatments for asthma
Pro Research Analysisby 
Searched over 200M research papers
Over-the-Counter Asthma Treatments: Types and Availability
Over-the-counter (OTC) treatments for asthma are primarily limited to inhalers containing epinephrine, such as Primatene Mist, which is approved for use in people aged 12 and older with mild, intermittent asthmaAschenbrenner2019Gaynes2022. These products are designed to provide quick relief from asthma symptoms without a prescription.
Safety and Effectiveness of OTC Asthma Inhalers
OTC epinephrine inhalers can be safe and effective for individuals with mild, intermittent asthma when used as directedDickinson2000Gaynes2022. However, misuse or overuse of these inhalers can lead to severe side effects, including potentially life-threatening reactionsDickinson2000Gaynes2022. There is concern that some people with more persistent or severe asthma may use OTC inhalers instead of seeking proper medical care, which can result in undertreated asthma and increased health risksDickinson2000Gaynes2022.
Risks of Overusing OTC Short-Acting Beta-2 Agonists (SABA)
Short-acting beta-2 agonists (SABA), such as albuterol, are commonly used for quick asthma relief. When available OTC, these medications are often overused, leading to poor asthma control, increased risk of severe asthma attacks, and higher healthcare utilizationLoh2023Azzi2019Reddel2017+1 MORE. Studies show that a significant proportion of OTC SABA users do not use preventive medications (like inhaled corticosteroids), which further increases their risk of uncontrolled asthma and urgent healthcare needsLoh2023Azzi2019Reddel2017+1 MORE.
Patient Behaviors and Outcomes with OTC Asthma Medications
Research indicates that many people who purchase OTC asthma relievers have suboptimal asthma control, poor adherence to preventive treatments, and sometimes lack a formal asthma diagnosisAzzi2019Reddel2017. Overuse of relievers without preventers is linked to more frequent urgent healthcare visits and worse asthma outcomesAzzi2019Reddel2017Khattab2022. Additionally, patients who buy relievers OTC are less likely to have regular asthma reviews with a healthcare provider.
Calls for Improved OTC Options and Patient Education
Recent guidelines recommend that inhaled corticosteroid (ICS)/formoterol combinations, which are safer and more effective than SABA alone, should be made more widely available, potentially even OTCBeasley2022Gerald2014. Making these combination inhalers available OTC could improve asthma outcomes, especially for disadvantaged populations, by ensuring that patients receive both quick relief and anti-inflammatory treatment at the same timeBeasley2022Gerald2014. However, regulatory and practical barriers currently limit access to these options in many countries.
Debate Over Expanding OTC Asthma Medication Access
There is ongoing debate about whether more asthma medications should be available OTC. Proponents argue that easier access could improve adherence and reduce barriers to treatment. Opponents warn that it could lead to increased misuse, poorer asthma control, and higher healthcare costs if patients self-manage without proper medical oversightMilgram2014Gaynes2022.
Conclusion
OTC asthma treatments, mainly epinephrine inhalers and SABA, are intended for mild, intermittent asthma but carry significant risks if misused or overused, especially without concurrent use of preventive medications. Overuse is common and linked to poor asthma control and increased urgent healthcare needs. There is growing support for making safer, more effective combination inhalers available OTC, but this requires careful regulation and improved patient education to ensure safe and effective asthma managementLoh2023Beasley2022Gerald2014+4 MORE.
Sources and full results
Most relevant research papers on this topic